Key result
Adults with congenital heart disease were more likely to have inpatient admissions in the last 30 days of life compared to patients with cancer.
Why the study?
How does end-of-life hospital resource utilization and advance care planning in adults with congenital heart disease compare to patients with cancer or heart failure?
Cohort (n=14,658)
Yes
How does end-of-life hospital resource utilization and advance care planning in adults with congenital heart disease compare to patients with cancer or heart failure?
Answers are grounded in this paper and cite their sources.
Adults with congenital heart disease experience significantly higher hospital resource utilization and likelihood of in-hospital death near the end of life compared to cancer patients, highlighting a need for improved palliative care.
OBJECTIVE: Overall health care resource utilization by adults with congenital heart disease has increased dramatically in the past two decades, yet little is known about utilization patterns at the end of life. The objective of this study is to better understand the patterns and influences on end-of-life care intensity for adults with congenital heart disease. METHODS: We identified a sample of adults with congenital heart disease (n = 65), cancer (n = 10 784), or heart failure (n = 3809) who died between January 2010 and December 2015, cared for in one multi-hospital health care system. We used multivariate analysis to evaluate markers of resource utilization, location of death, and documentation of advance care planning among patients with congenital heart disease versus those with cancer and those with heart failure. RESULTS: Approximately 40% of adults with congenital heart disease experienced inpatient and intensive care unit (ICU) hospitalizations in the last 30 days of life; 64% died in the hospital. Compared to patients with cancer, patients with adult congenital heart disease (ACHD) were more likely to have inpatient (adjusted risk ratio 1.57; 95% CI 1.12-2.18) and ICU admissions in the last 30 days of life (adjusted risk ratio 2.56; 95% CI 1.83-3.61), more likely to die in the hospital (adjusted risk ratio 1.75; 95% CI 1.43-2.13), and more likely to have documentation of advance care planning (adjusted risk ratio 1.46; 95% CI 1.09-1.96). Compared to patients with heart failure (HF), patients with ACHD were less likely to have an ICU admission in the last 30 days of life (adjusted risk ratio 0.73; 95% CI 0.54-0.99). CONCLUSIONS: Adults with congenital heart disease have significant hospital resource utilization near the end of life compared to patients with cancer, notable for more hospitalizations and a higher likelihood of death in the hospital. This population represents an important opportunity for the application of palliative and supportive care.
No takes yet. Share an insight, caveat, or question.
Steiner et al. (2018) conducted a cohort in Congenital heart disease, cancer, or heart failure at the end of life (n=14,658). Adult congenital heart disease vs. Cancer or heart failure was evaluated on Inpatient admissions in the last 30 days of life (vs cancer) (adjusted RR 1.57, 95% CI 1.12-2.18). Adults with congenital heart disease were more likely to have inpatient admissions in the last 30 days of life compared to patients with cancer.
Synapse has enriched 10 related papers. Consider them for comparative context: